59721-28-7 Usage
General Description
Camostat is a synthetic serine protease inhibitor that is used to treat chronic pancreatitis and other pancreatic disorders. It works by inhibiting the activity of trypsin, a serine protease that can cause inflammation and tissue damage in the pancreas. Camostat has also been investigated for its potential to treat other conditions, including cancer, viral infections, and fibrotic diseases. It has been shown to have anti-inflammatory and anti-fibrotic properties, and is currently being studied for its potential therapeutic benefits in various medical fields. Overall, camostat is a promising compound with a wide range of potential applications in medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 59721-28-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,9,7,2 and 1 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 59721-28:
(7*5)+(6*9)+(5*7)+(4*2)+(3*1)+(2*2)+(1*8)=147
147 % 10 = 7
So 59721-28-7 is a valid CAS Registry Number.
InChI:InChI=1/C20H22N4O5/c1-24(2)17(25)12-28-18(26)11-13-3-9-16(10-4-13)29-19(27)14-5-7-15(8-6-14)23-20(21)22/h3-10H,11-12H2,1-2H3,(H4,21,22,23)
59721-28-7Relevant articles and documents
Acyl guanidine compound as well as preparation method and application thereof
-
Paragraph 0030, (2020/10/14)
The invention discloses an acyl guanidine compound with a structure as shown in a formula I (See the specification) and pharmaceutically acceptable salt thereof. The invention also discloses a preparation method of the compound. The invention also discloses a pharmaceutical composition taking the compound or pharmaceutically acceptable salt thereof as an active ingredient, and their application tothe prevention or treatment of diseases (such as hypertension, chronic congestive heart failure, antidiuretic hormone secretion disorder syndrome or hyponatremia caused by chronic heart failure/livercirrhosis/antidiuretic hormone secretion disorder) related to an arginine vasopressin V1a receptor, an arginine vasopressin V1b receptor and an arginine vasopressin V2 receptor.